UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046834
Receipt number R000052005
Scientific Title Effects of Intra-Arterial Infusion of temporary embolic material for hand osteoarthritis Refractory to Conservative Treatment: A Retrospective Study
Date of disclosure of the study information 2022/02/10
Last modified on 2022/03/28 01:15:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Intra-Arterial Infusion of temporary embolic material for hand osteoarthritis Refractory to Conservative Treatment: A Retrospective Study

Acronym

Retrospective study of simplified TAE For hand OA

Scientific Title

Effects of Intra-Arterial Infusion of temporary embolic material for hand osteoarthritis Refractory to Conservative Treatment: A Retrospective Study

Scientific Title:Acronym

Retrospective study of simplified TAE For hand OA

Region

Japan


Condition

Condition

osteoarthritis in DIP/PIP joints

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy of simplified TAE for patients with refractory hand OA

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of pain score at 1 year follow up

Key secondary outcomes

Complications
Change of Quick DASH score
pain PGIC
swelling PGIC
redness PGIC


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

we perform a retrospective study assessing the clinical course of patients who underwent simplified TAE during 2019 to 2020

Key exclusion criteria

None

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yuji
Middle name
Last name Okuno

Organization

Okuno Clinic.

Division name

Musculoskeletal Intervention Center

Zip code

1060032

Address

4th Fl Ginrrei Bldg. 7-8-4, Roppongi, Minato-ku, Tokyo

TEL

+81-3-6801-6539

Email

okuno@okuno-y-clinic.com


Public contact

Name of contact person

1st name Yosuke
Middle name
Last name Fujiwara

Organization

Okuno Clinic.

Division name

Clinical Research Center

Zip code

1060032

Address

4th Fl Ginrrei Bldg. 7-8-4, Roppongi, Minato-ku, Tokyo

TEL

+81-3-6801-6539

Homepage URL


Email

fujiwara@okuno-y-clinic.com


Sponsor or person

Institute

Okuno Clinic.

Institute

Department

Personal name



Funding Source

Organization

TAME Study group

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical committee of Okuno Clinic.

Address

4th Fl Ginrrei Bldg. 7-8-4, Roppongi, Minato-ku, Tokyo

Tel

+81-3-6801-6539

Email

fujiwara@okuno-y-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

101

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 12 Month 07 Day

Date of IRB

2022 Year 01 Month 10 Day

Anticipated trial start date

2022 Year 01 Month 11 Day

Last follow-up date

2022 Year 03 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We retrospectively evaluated the patients who underwent TAE for hand OA between January 2019 and December 2020.


Management information

Registered date

2022 Year 02 Month 04 Day

Last modified on

2022 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052005